Source: CompanyNews HQ

Kiadis Pharma: Conversion of Kiadis to a private limited liability company postponed until completion of statutory buy-out proceedings

This is a joint press release by Sanofi Foreign Participations B.V. (the "Offeror"), Sanofi ("Sanofi") and Kiadis Pharma N.V. ("Kiadis") View post on CompanyNewsHQ: Conversion of Kiadis to a private limited liability company postponed until completion of statutory buy-out proceedings

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Arthur Lahr's photo - CEO of Kiadis Pharma

CEO

Arthur Lahr

CEO Approval Rating

86/100

Read more